|
1
|
James PA, Oparil S, Carter BL, Cushman WC,
Dennison -Himmelfarb C, Handler J, Lackland DT, LeFevre ML,
MacKenzie TD, Ogedegbe O, et al: 2014 evidence-based guideline for
the management of high blood pressure in adults: Report from the
panel members appointed to the Eighth Joint National Committee (JNC
8). JAMA. 311:507–520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kearney PM, Whelton M, Reynolds K, Muntner
P, Whelton PK and He J: Global burden of hypertension: Analysis of
worldwide data. Lancet. 365:217–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hart PD and Bakris GL: Hypertensive
nephropathy: Prevention and treatment recommendations. Expert Opin
Pharmacother. 11:2675–2686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Christiansen RE, Tenstad O, Leh S and
Iversen BM: Glomerular charge selectivity is impaired in
hypertensive nephropathy. Nephrol Dial Transplant. 19:1083–1091.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fauvel JP and Laville M: Hypertensive
nephropathy: A growing cause of renal insufficiency. Presse Med.
30:81–86. 2001.(In French). PubMed/NCBI
|
|
6
|
Rouse RL, Stewart SR, Thompson KL and
Zhang J: Kidney injury biomarkers in hypertensive, diabetic, and
nephropathy rat models treated with contrast media. Toxicol Pathol.
41:662–680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahajan A, Simoni J, Sheather SJ, Broglio
KR, Rajab MH and Wesson DE: Daily oral sodium bicarbonate preserves
glomerular filtration rate by slowing its decline in early
hypertensive nephropathy. Kidney Int. 78:303–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tylicki L and Rutkowski B: Hypertensive
nephropathy: pathogenesis, diagnosis and treatment. Pol Merkuriusz
Lek. 14:168–173. 2003.(In Polish).
|
|
9
|
Aksun SA, Ozmen D, Ozmen B, Parildar Z,
Mutaf I, Turgan N, Habif S, Kumanlioğluc K and Bayindir O:
Beta2-microglobulin and cystatin C in type 2 diabetes: Assessment
of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 112:195–200.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen H and Li H: Clinical implication of
cystatin C and β2-microglobulin in early detection of diabetic
nephropathy. Clin Lab. 63:241–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nozue T, Michishita I and Mizuguchi I:
Predictive value of serum cystatin C, β2-microglobulin, and urinary
liver-type fatty acid-binding protein on the development of
contrast-induced nephropathy. Cardiovasc Interv Ther. 25:85–90.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurashige T, Takahashi T, Yamazaki Y,
Nagano Y, Kondo K, Nakamura T, Yamawaki T, Tsuburaya R, Hayashi YK,
Nonaka I, et al: Elevated urinary β2 microglobulin in the first
identified Japanese family afflicted by X-linked myopathy with
excessive autophagy. Neuromuscul Disord. 23:911–916. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stakhova TIu, Shcherbak AV, Kozlovskaia
LV, Taranova MV and Balkarov IM: Clinical value of the
determination of markers for endothelial dysfunction (endothelin-1,
microalbuminuria) and tubulointerstitial tissue lesion
(β2-microglobulin, monocyte chemotactic protein-1) in hypertensive
patients with uric acid metabolic disorders. Ter Arkh. 86:45–51.
2014.(In Russian). PubMed/NCBI
|
|
14
|
Liu GX, Li YQ, Huang XR, Wei LH, Zhang Y,
Feng M, Meng XM, Chen HY, Shi YJ and Lan HY: Smad7 inhibits
AngII-mediated hypertensive nephropathy in a mouse model of
hypertension. Clin Sci. 127:195–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu GX, Li YQ, Huang XR, Wei L, Chen HY,
Shi YJ, Heuchel RL and Lan HY: Disruption of Smad7 promotes ANG
II-mediated renal inflammation and fibrosis via
Sp1-TGF-β/Smad3-NFκB-dependent mechanisms in mice. PLoS One.
8:e535732013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klingbeil AU, Schneider M, Martus P,
Messerli FH and Schmieder RE: A meta-analysis of the effects of
treatment on left ventricular mass in essential hypertension. Am J
Med. 115:41–46. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Staessen JA, Wang J, Bianchi G and
Birkenhäger WH: Essential hypertension. Lancet. 361:1629–1641.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schillaci G, Pirro M, Mannarino MR, Pucci
G, Savarese G, Franklin SS and Mannarino E: Relation between renal
function within the normal range and central and peripheral
arterial stiffness in hypertension. Hypertension. 48:616–621. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leoncini G, Viazzi F, Conti N, Baratto E,
Tomolillo C, Bezante GP, Deferrari G and Pontremoli R: Renal and
cardiac abnormalities in primary hypertension. J Hypertens.
27:1064–1073. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin JR, Kim SM, Yoo JS, Park JY, Kim SK,
Cho JH, Jeong KH, Lee TW and Ihm CG: Urinary excretion of
β2-microglobulin as a prognostic marker in immunoglobulin A
nephropathy. Korean J Intern Med. 29:334–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mohamed RH, Abdel-Aziz HR, Abd El Motteleb
DM and Abd El-Aziz TA: Effect of RAS inhibition on TGF-β, renal
function and structure in experimentally induced diabetic
hypertensive nephropathy rats. Biomed Pharmacother. 67:209–214.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dieterle F, Perentes E, Cordier A, Roth
DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, et al:
Urinary clusterin, cystatin C, beta2-microglobulin and total
protein as markers to detect drug-induced kidney injury. Nat
Biotechnol. 28:463–469. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bicik Z, Gönen S, Bahçebasi T, Reis K,
Arinsoy T and Sindel S: Role of transforming growth factor-β2 in,
and apossible transforming growth factor-β 2 gene polymorphism as a
marker of, renal dysfunction in essential hypertension: A study in
Turkish patients. Curr Ther Res Clin Exp. 66:266–278. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kurts C, Panzer U, Anders HJ and Rees AJ:
The immune system and kidney disease: Basic concepts and clinical
implications. Nat Rev Immunol. 13:738–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
